Simpatectomia torácica por videotoracoscopia: revisão da literatura.

Nicolini, Eveline Montessi; Costa, V.; Montessi, Jorge; Rodrigues, Guilherme de Abreu; Cangussu, Victor Vitoi; Reis, Ana Flávia Miranda; Filho, Flávio Vieira Marques

doi:10.1590/0100-6991e-20192157

Cited by 5 publications

(5 citation statements)

References 24 publications

(21 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…ETS is considered a safe and efficient procedure for the treatment of hyperhidrosis. 7,8,15,16,[30][31][32][33] Despite its widespread use in clinical practice, there is still no population-based report on its mortality rates. In our nationwide database, we observed 6 in-hospital casualties sparsely distributed among Brazilian regions and over time, corresponding to an overall mortality rate of 0.045%.…”

Section: Discussionmentioning

confidence: 99%

Nationwide Cross-sectional Analysis of Endoscopic Thoracic Sympathectomy to Treat Hyperhidrosis Over 12 years in Brazil

et al. 2023

View full text Add to dashboard Cite

Objective: To analyze the number of endoscopic thoracic sympathectomies performed to treat hyperhidrosis in the Universal Public Health System of Brazil, the government reimbursements, and the in-hospital mortality rates. Background: Even though endoscopic thoracic sympathectomy has been widely performed for the definitive treatment of hyperhidrosis, no series reported mortality and there are no population-based studies evaluating its costs or its mortality rate. Methods: Data referring to endoscopic thoracic sympathectomy to treat hyperhidrosis between 2008 and 2019 were extracted from the database of the Brazilian Public Health System, which insures more than 160 million inhabitants. Results: Thirteen thousand two hundred one endoscopic thoracic sympathectomies to treat hyperhidrosis were performed from 2008 to 2019, with a rate of 68.44 procedures per 10 million inhabitants per year. There were 6 in-hospital deaths during the whole period, representing a mortality rate of 0.045%. The total expended throughout the years was U$ 6,767,825.14, with an average of U$ 512.68 per patient. Conclusions: We observed a rate of 68.44 thoracoscopic sympathectomies for hyperhidrosis' treatment per 10 million inhabitants per year. The inhospital mortality rate was very low, 0.045%, though not nil. To our knowledge, no published series is larger than ours and we are the first authors to formally report deaths after endoscopic thoracic sympathectomies to treat hyperhidrosis. Moreover, there is no other population-based study addressing costs and mortality rates of every endoscopic thoracic sympathectomy for the treatment of any site of hyperhidrosis in a given period.

show abstract

Section: Discussionmentioning

confidence: 99%

Nationwide Cross-sectional Analysis of Endoscopic Thoracic Sympathectomy to Treat Hyperhidrosis Over 12 years in Brazil

et al. 2023

View full text Add to dashboard Cite

show abstract

“…Başka bir çalışmada ise ortalama yaş 31.1 yıl ve %69 oranında erkek yoğunluğu vardı [4] . Hiperhidrozis en sık palmar ve aksiller bölgede gözlenmektedir [5,8,9] . Çoğunluğunun soy geçmişinde hastalık öyküsü vardır [1] .…”

Section: Discussionunclassified

“…Primer hiperhidrozis tedavi seçenekleri arasında topikal, antikolinerjik ve b-blokerler, botilismus toksini, iyontoferez, videotorakoskopik sempatektomi yer almaktadır. [2] Bu tedaviler içinde yer alan videotorakoskopik sempatektomi en etkili tedavi yöntemidir [8,9] . Çalışmadan çalışmaya ve zaman içerisinde gelişen deneyimlere bağlı olarak işlem yapılan sempatik lokalizasyon seviyesi değişmektedir [12] .…”

Section: Discussionunclassified

Primer Hiperhidroz Tedavisinde Videotorakoskopik Sempatektominin Yaşam Kalitesine Etkisi: Tek Merkez Deneyimi

Sezer¹,

Eliçora²

2021

GKDA Derg

View full text Add to dashboard Cite

Objective: In our study, we aimed to reveal the change in the level of quality of life in patients who underwent videothoracoscopic sympathectomy due to hyperhidrosis. Methods: Data of 40 patients who were treated with videothoracoscopic sympathectomy for primary hyperhidrosis were analyzed retrospectively. The Turkish version of the “The Hyperhidrosis Quality of Life Questionnaire (HQLQ)” was used in the assessment of the quality of life. Results: The mean total questionnaire scores before the operation was 82.08±1.46, 31.40±0.59 at the first month after the operation, and 31.30±0.46 at the first year after the operation. While a statistically significant difference was found between the pre-operative total survey score averages and the postoperative 1st month and 1st year survey score averages (p<0.001, p<0.001, respectively),a statistically significant difference was not detected between total score averages of the postoperative 1st month and 1st year (p=1.00). Conclusion: Videothoracoscopic sympathectomy method used in the treatment of primary hyperhidrosis is an effective, reliable method that significantly increases the quality of life.

show abstract

“…A clipagem por cirurgia videotoracoscópica (VATS) do ramo simpático, mais conhecida como simpatectomia, consiste na remoção do nervo simpático principal (NICOLINI et al, 2019), sendo que sua principal indicação é para pacientes com hiperidrose primária (DE CAMPOS; KAUFFMAN, 2007), a qual é uma condição caracterizada por uma sudorese excessiva gerada a partir de um estímulo intenso das glândulas sudoríparas écrinas (REZENDE et al, 2013). Esse procedimento é um método efetivo e seguro que melhora a qualidade de vida do paciente, mas pode acarretar complicações no pós-operatório, como a hiperidrose compensatória (REZENDE et al, 2013).…”

Section: Introductionunclassified